Supernus Pharmaceuticals reported $11.35M in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbott ABT:US USD 1.64B 135M
Ani Pharmaceuticals ANIP:US USD -3454000 6.78M
Aurora Cannabis Inc ACB:CN CAD -73026000 13.79M
Bristol Myers Squibb BMY:US USD 2.74B 461M
Canopy Growth Corp WEED:CN CAD -117273000 11.22M
Cara Therapeutics CARA:US USD -23845000 19.37M
Corcept Therapeutics CORT:US USD 31.93M 502K
Eisai 4523:JP JPY -2181000000 9.62B
Eli Lilly And LLY:US USD 1.95B 294.9M
Endo International Ordinary Shares ENDP:US USD 55.64M 26.07M
Horizon Pharma HZNP:US USD 188.16M 41.16M
Lannett LCI:US USD -11277000 12.66M
Marinus Pharmaceuticals MRNS:US USD -30099000 6.67M
Pacira Pharmaceuticals PCRX:US USD 21.78M 8.6M
Perrigo Ordinary Shares PRGO:US USD 52.2M 49.6M
Pfizer PFE:US USD 9.7B 2.43B
Revance Therapeutics RVNC:US USD -77484000 19.64M
Teva Pharmaceutical Industries TEVA:US USD 740M 6M
United Therapeutics UTHR:US USD 314.3M 112.5M
Xeris Pharmaceuticals Inc XERS:US USD -18780000 136K